| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lexeo Therapeutics, Inc. | Director | Stock Option (right to buy) | 25K | Jun 26, 2025 | Direct | ||
| scPharmaceuticals Inc. | Director | Stock Option (Right to Buy) | 0 | Oct 7, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SCPH | scPharmaceuticals Inc. | Oct 7, 2025 | 2 | $0 | 4 | Oct 7, 2025 | Director |
| LXEO | Lexeo Therapeutics, Inc. | Jun 26, 2025 | 1 | $0 | 4 | Jun 30, 2025 | Director |
| SCPH | scPharmaceuticals Inc. | Jun 3, 2025 | 1 | $0 | 4 | Jun 5, 2025 | Director |
| LXEO | Lexeo Therapeutics, Inc. | Jun 25, 2024 | 1 | $0 | 4 | Jun 27, 2024 | Director |
| SCPH | scPharmaceuticals Inc. | Jun 11, 2024 | 1 | $0 | 4 | Jun 13, 2024 | Director |
| LXEO | Lexeo Therapeutics, Inc. | Feb 2, 2024 | 1 | $0 | 4 | Feb 6, 2024 | Director |
| LXEO | Lexeo Therapeutics, Inc. | Nov 2, 2023 | 0 | $0 | 3 | Nov 2, 2023 | Director |
| SCPH | scPharmaceuticals Inc. | Jun 6, 2023 | 1 | $0 | 4 | Jun 8, 2023 | Director |